Patents Assigned to EMEK, Inc.
  • Patent number: 11058702
    Abstract: Provided are methods of treating a human patient having cancer by administering IPdR to the patient in the form of an oral drug and administering radiation therapy (RT) to the patient. The method can also include administering a chemotherapeutic drug or biologic agent to the patient. Also provided are methods for optimizing IPdR sensitization for radiation therapy for a cancer patient having been administered IPdR.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: July 13, 2021
    Assignee: EMEK, INC.
    Inventor: Timothy J. Kinsella
  • Publication number: 20200069718
    Abstract: Provided are methods of treating a human patient having cancer by administering IPdR to the patient in the form of an oral drug and administering radiation therapy (RT) to the patient. The method can also include administering a chemotherapeutic drug or biologic agent to the patient. Also provided are methods for optimizing IPdR sensitization for radiation therapy for a cancer patient having been administered IPdR.
    Type: Application
    Filed: May 15, 2019
    Publication date: March 5, 2020
    Applicant: EMEK, Inc.
    Inventor: Timothy J. Kinsella
  • Publication number: 20170266217
    Abstract: Provided are methods of treating a human patient having cancer by administering IPdR to the patient in the form of an oral drug and administering radiation therapy (RT) to the patient. The method can also include administering a chemotherapeutic drug or biologic agent to the patient. Also provided are methods for optimizing IPdR sensitization for radiation therapy for a cancer patient having been administered IPdR.
    Type: Application
    Filed: March 31, 2017
    Publication date: September 21, 2017
    Applicant: EMEK, Inc.
    Inventor: Timothy J. Kinsella